Asthma And Stepwise Management NURS 6521
Walden University Asthma And Stepwise Management NURS 6521-Step-By-Step Guide
This guide will demonstrate how to complete the Walden University Asthma And Stepwise Management NURS 6521 assignment based on general principles of academic writing. Here, we will show you the A, B, Cs of completing an academic paper, irrespective of the instructions. After guiding you through what to do, the guide will leave one or two sample essays at the end to highlight the various sections discussed below.
How to Research and Prepare for Asthma And Stepwise Management NURS 6521
Whether one passes or fails an academic assignment such as the Walden University Asthma And Stepwise Management NURS 6521 depends on the preparation done beforehand. The first thing to do once you receive an assignment is to quickly skim through the requirements. Once that is done, start going through the instructions one by one to clearly understand what the instructor wants. The most important thing here is to understand the required format—whether it is APA, MLA, Chicago, etc.
After understanding the requirements of the paper, the next phase is to gather relevant materials. The first place to start the research process is the weekly resources. Go through the resources provided in the instructions to determine which ones fit the assignment. After reviewing the provided resources, use the university library to search for additional resources. After gathering sufficient and necessary resources, you are now ready to start drafting your paper.
How to Write the Introduction for Asthma And Stepwise Management NURS 6521
The introduction for the Walden University Asthma And Stepwise Management NURS 6521 is where you tell the instructor what your paper will encompass. In three to four statements, highlight the important points that will form the basis of your paper. Here, you can include statistics to show the importance of the topic you will be discussing. At the end of the introduction, write a clear purpose statement outlining what exactly will be contained in the paper. This statement will start with “The purpose of this paper…” and then proceed to outline the various sections of the instructions.
Struggling to Meet Your Deadline?
Get your assignment on Asthma And Stepwise Management NURS 6521 done on time by medical experts. Don’t wait – ORDER NOW!
How to Write the Body for Asthma And Stepwise Management NURS 6521
After the introduction, move into the main part of the Asthma And Stepwise Management NURS 6521 assignment, which is the body. Given that the paper you will be writing is not experimental, the way you organize the headings and subheadings of your paper is critically important. In some cases, you might have to use more subheadings to properly organize the assignment. The organization will depend on the rubric provided. Carefully examine the rubric, as it will contain all the detailed requirements of the assignment. Sometimes, the rubric will have information that the normal instructions lack.
Another important factor to consider at this point is how to do citations. In-text citations are fundamental as they support the arguments and points you make in the paper. At this point, the resources gathered at the beginning will come in handy. Integrating the ideas of the authors with your own will ensure that you produce a comprehensive paper. Also, follow the given citation format. In most cases, APA 7 is the preferred format for nursing assignments.
How to Write the Conclusion for Asthma And Stepwise Management NURS 6521
After completing the main sections, write the conclusion of your paper. The conclusion is a summary of the main points you made in your paper. However, you need to rewrite the points and not simply copy and paste them. By restating the points from each subheading, you will provide a nuanced overview of the assignment to the reader.
How to Format the References List for Asthma And Stepwise Management NURS 6521
The very last part of your paper involves listing the sources used in your paper. These sources should be listed in alphabetical order and double-spaced. Additionally, use a hanging indent for each source that appears in this list. Lastly, only the sources cited within the body of the paper should appear here.
Stuck? Let Us Help You
Completing assignments can sometimes be overwhelming, especially with the multitude of academic and personal responsibilities you may have. If you find yourself stuck or unsure at any point in the process, don’t hesitate to reach out for professional assistance. Our assignment writing services are designed to help you achieve your academic goals with ease.
Our team of experienced writers is well-versed in academic writing and familiar with the specific requirements of the Asthma And Stepwise Management NURS 6521 assignment. We can provide you with personalized support, ensuring your assignment is well-researched, properly formatted, and thoroughly edited. Get a feel of the quality we guarantee – ORDER NOW.
A Sample Answer For the Assignment: ASTHMA AND STEPWISE MANAGEMENT NURS 6521
Introduction
Asthma is a chronic, inflammatory disease which affects the airways. It is associated with various symptoms such as wheezing, difficulty in breathing, chest pain, and cyanosis in severe cases. It is very prevalent in America where 22 million people are affected. The situation raises hospitalization levels to more than 497,000 annually (Kirenga et al., 2018). With such a high number, the country is significantly affected both economically and socially. Many children missed school days due to asthma and some caregivers are also forced to leave work to take care of their sick children. As productivity of the country lowers, a lot of money is used in managing the disease (Rothe et al., 2018). However, treatment options have been improved to address the situation.
Treatment Options
Both quick-relief and long control medicines are used in treating asthma. Long-term control medicines (also called controller medicines or maintenance medicines). Long-acting beta-adrenergic (LABA) is one of the quick relief medication used. The LABAs help in providing long-term control of symptoms (Kirenga et al., 2018). Inhaled corticosteroids (ICS) are commonly used as anti-inflammatory drugs because they reduce inflammation caused by a vast diversity of inflammatory mediators (Yawn & Han, 2017). Rothe et al. (2018) highlight omalizumab (Xolair) as the most common Immuno-modulators used to prevent the binding of IgE to its receptor and in turn, inhibit IgE-mediated asthma from cascading before it begins.
Long-term control drugs
•There are several stated models of treatment of asthma. However, the major ones include bronchodilators and anti-inflammatory drugs. Bronchodilators include: beta 2 selective agonists, muscarinic antagonists, xanthine derivatives, leukotriene receptor blockers and anticholinergics. Anti- inflammatory drugs include: corticosteroids and mast cell stabilizers.
•These Long-term control drugs : Long acting beta-2 agonists (LABA), Methylxanthines, Inhaled corticosteroids, Leukotriene receptor antagonists and Cromolyn.
1. Long- acting beta-2 agonists (LABA) mode of action is by activating the pre-junctional β2-adrenoceptors and reduce acetylcholine release thereby prevent any functional competition by acetylcholine .
•They include drugs such as: Salmeterol, formoterol and olodaterol
•The therapeutic effects include: improving lung function, increase number of asthma symptom free days, reduce the asthma symptoms and reduce number of asthma attacks.
•However they include contraindications and adverse effects whereby in a drug such as salmeterol caution should be taken in use by African Americans and for (LABA) should be used with an oral glucocorticoid to minimize various risks and shouldn’t be used alone for prophylaxis as it can lead to increased risk of severe asthma attacks and asthma related deaths.
2. Methylxanthines mode of action is through non-competitive inhibition of the phosphodiesterase enzyme, methylxanthines cause an intracellular increase in levels of cyclic adenosine monophosphate and cyclic guanosine monophosphate.
•Here the most common drug used is theophylline.
•The therapeutic effects involve it preventing and treating wheezing, shortness of breath, and chest tightness caused by asthma.
•However it also has contraindications and adverse effects whereby caution should be taken in patients with heart disease, seizure disorders and liver dysfunction and its adverse effects involve toxicity, severe dysrhythmias and even death
Inhaled corticosteroids mode of action is by suppressing inflammation through decreasing inflammatory mediators, decreasing activity of inflammatory cells and decreasing edema of airway mucosa.
•The inhaled corticosteroids include drugs such as budesonide, fluticasone propionate, ciclesonide and beclomethasone.
•The therapeutic effects involve reducing inflammation, reducing production of mucus, improve response to bronchodilators and reduce potential of dyspnea.
•However there are contraindications and adverse effects involved such as caution should be observed in patients tested positive with candida albicans and its adverse effects involve it could lead to candidiasis development and decreased growth.
4. Leukotriene receptor antagonists mode of action is by preventing leukotriene release from mast cells and eosinophils or by blocking the specific leukotriene receptors on bronchial tissues it also reduces the influx of eosinophils, thus limiting inflammatory damage in the airway.
•The main drugs prescribed here are montelukast and zafirlukast.
•The therapeutic effects involve it prevents bronchoconstriction, mucus secretion and edema thus having open airways.
•However there are contraindications and adverse effects involved such as it shouldn’t be used in patients with a hypersensitivity to it or with hepatic impairment and its adverse effects involve it could lead to fever, headache, cough, sore throat and risk of upper respiratory infections.
Short-term control drugs
•These involves drugs such as: Short acting beta-2 agonists (SABA), Anticholinergics and Oral corticosteroids.
1. Short acting beta-2 agonists mode of action is through activates the beta-2 receptor, and this helps relax the bronchial tubes within five minutes.
•Drugs involved her include albuterol, levalbuterol, isoproterenol and terbutaline sulphate.
•The therapeutic effects include: relieving of symptoms of asthma attack such as dyspnea, wheezing and coughing.
•Contraindications and adverse effects are also involved in these drugs such as caution should be taken in patients with heart disease, diabetes and hypertension then on the adverse effects there are usually no adverse effects as long as patient is compliant with the practitioner’s instruction though one may experience mild effects such as headaches, trembling and nervousness.
2. Anticholinergics mode of action is through activates the beta-2 receptor, and this helps relax the bronchial tubes within five minutes.
•Drugs involved her include alcidinium and ipratropium bromide.
•The therapeutic effects include: reducing inflammation, decrease mucus production in the airways and prevent bronchospasms.
•Contraindications and adverse effects are also involved in these drugs such as caution should be taken in patients with heart disease, hypertension and myasthenia the adverse effects include dry mouth, constipation, urinary retention, bowel obstruction, dilated pupils, blurred vision, increased heart rate, and decreased sweating.
•These involves drugs such as: Short acting beta-2 agonists (SABA), Anticholinergics and Oral corticosteroids.
3. Oral Corticosteroids mode of action is through binding to intracellular receptors which then act to modulate gene transcription in target tissues .
•Drugs involved her include: prednisone, prednisolone, methylprednisolone and dexamethasone.
•The therapeutic effects include: reduce inflammation and swelling in the airways they also relieve asthma related symptoms, such as body pain, swelling, and stiffness.Contraindications and adverse effects are also involved in these drugs such as caution should be taken in patients with
Stepwise-approach to asthma treatment and management
•It involves six steps whereby in the first step a short acting beta-2 agonists (SABA) is used when necessary such as albuterol.
•In the second step when the asthma is persistent a low dose inhaled corticosteroid is used or alternatively a methylxanthine such as theophylline is used.
•In the third step preferably a low dose inhaled corticosteroid is used together with a long acting beta- 2 agonist or alternatively a low dose inhaled corticosteroid and either theophylline or leukotriene receptor antagonists .
•In the fourth step preferably a medium dose inhaled corticosteroid and a long acting beta-2 agonist or alternatively medium dose inhaled corticosteroid with theophylline.
•In the fifth step a high dose inhaled corticosteroid is used together with a long acting beta- 2 agonist is preferred and omalizumab can be considered for patients with allergies.
•In the sixth step a high dose inhaled corticosteroid with a long acting beta- 2 agonist and an oral corticosteroid is preferred and the same omalizumab should be considered for patients with allergies.
•The drugs used change depending on the category asthma condition they are in whether it is intermittent, mild persistent, moderate persistent or severe.
Stepwise management use in controlling the disease
•The six steps involved are used to benefit the patient in the phase of the patient’s asthma whether it is intermittent, mild persistent, moderate persistent or severe.
•One is able to step up or step down in the steps involved if relief is found and vice-versa and throughout one should have a short acting beta-2 agonist. The effectiveness of it should be assesses by the heard breath sounds.
•If relief is not heard one steps up. The stepwise approach helps to not the category of the condition of the patient and the effectivity of the medication. If the medication is not working it helps the practitioner determine what the next course of treatment is as it is indicated in the steps depending on the ,medication listed on that step.
•Then in the case of relief the drugs the patient to use as they are stepping down.
•It also aids healthcare providers in identifying alternatives that can be used if the preferred one can’t be used such as a low dose inhaled corticosteroid and either theophylline or leukotriene receptor antagonists in the third step.
•It also aids the patient in knowing the level of symptoms and which category they are in whether it is intermittent, mild persistent, moderate persistent or severe.
•The patient is also able self- examine themselves and identify if symptoms are worsening to prevent from reaching that stage and use the medication in the step they are situated in such as if they are still in intermittent asthma they use medication as directed in the first step and don’t let it get to persistent asthma that requires another regimen that is daily medication. Having exercise induced bronchospasm is an indicator for inadequate asthma control.
•The patient benefits also by gaining relevant information on how to use the various drugs, the potential side effects and their management together with other significant health education such as chronic use of high dose inhaled corticosteroids could lead to osteoporosis.
Advanced practice nurses offer treatment for respiratory disorders.
Asthma is one of such disorders.
Asthma adversely affects a patient’s airways.
The condition requires a consistent management.
Patients experience mucus production, inflammation and bronchospasm.
This presentation explores step-wise management.
The advanced practice nurses have the expertise to offer patient care services to patient having various conditions such as respiratory conditions or disorders. Among the disorders is asthma with is a respiratory that impacts both adults and children. Asthma can present in varied magnitude with some being mild while others can be life-threatening, as such, the nurses have to distinguish the type for better care services. Asthma adversely impacts the patient’s airways hence requires a consistent management
from the care team. The kind of management strategy employed in most cases depends on the age, symptoms and severity (Leas et al., 2018). Therefore, this presentation explores the step-wise approach of asthma management.
qThe long-term treatment strategies inhibit asthma attacks.
qChronic symptoms are also controlled through the strategy.
qThey include:
üTheophylline
üLong-acting beta agonists
üLeukotriene modifiers
üInhaled corticosteroids
üCombining corticosteroids and long-acting beta agonist.
As earlier indicated, the management strategy applied for patients experiencing asthma depends on the patient’s age, and the severity of the symptoms. The implication is that a clinician goes for either short-term/quick relief or long-term treatment strategies. When the long term option is chosen, then various options exists such as theophylline which relieves the patient by relaxing the muscles which cause the airways to narrow. The long-acting beta agonists like salmeterol operate as bronchodilators and function in a patient’s body for up to twelve hours. The Leukotriene modifiers like Accolate deals with swelling and smoothing the airway muscles. In addition, the corticosteroids follows an action that blocks the reaction to allergen and lowers the hyper responsiveness of the airways (Bleecker et al., 2020).
Apart from the long-term management options, the other option is recue or quick relief medication which are short term options. In most cases, patient use them for short term relief whenever they experience asthma attacks. Various categories of medications used as short term options also follow different mechanisms of action. The intravenous and oral corticosteroids like prednisone treat the airways inflammation which comes with severe asthma (Bleecker et al., 2020).
When medications are administered to patients, the medications can have either positive or negative impacts. The medications used in asthma treatment and management are no exception. It is also worth noting that these impacts may vary from one patient to another. These medications offer relief to patients experiencing asthma attacks. However, these medications can also have various negative impacts. Some of the negatives effects include rapid heart beats and cases of headache (Mahemuti et al., 2018). A patient using these medications may experience through fungal infection as wells sore mouth and throat which may lead to further patient’s pain.
qThe step-wise approach uses six steps.
qFirst step-administration of short-acting beta agonist (SABA)
qSecond step- offering low doses of SABA with corticosteroids.
qThird step –a combination of a low dose of ICS and the long acting beta agonists.
qFourth step- administration of the medium does of LABA-ICS.
qStep 5: SABA+LAMA, LABA+ ICS(Daily medium to high dose)
Step 6: administration of the high dose of steroids+SABA+LABA
The stepwise approach of asthma has been detailed by the National Asthma education and Prevention program (Cloutier et al.,2020). The management starting point depends on the severity of the symptoms as displayed by the patient. There are a total of six steps to follow with the first step having the lowest treatment dosage involving the use of short-acting beta agonists only. Step two entails the low doses of SABA and ICS give per day (Bernstein& Mansfield, 2019).
The third step also entails offering medications of low doses, but in this case LABA and ICS in combination on a daily basis. The fourth step entails a medium dose of a combination of LABA and ICS. The fifth step involves a high dose of SABA-LAMA-LABA-ICS. Finally the six step entails high dosage of the same.
. The anticholinergic agents are also used as short term options and act to immediately and quickly relax the airways. In addition, the short-acting beta agonists are inhaled as quick relief bronchodilators. They help a patient to be relived within a few minutes of using the medications. Some of them include albuterol and levalbuterol
Asthma is a chronic, inflammatory disease which affects the airways. It is associated with various symptoms such as wheezing, difficulty in breathing, chest pain, and cyanosis in severe cases. It is very prevalent in America where 22 million people are affected. The situation raises hospitalization levels to more than 497,000 annually (Kirenga et al., 2018). With such a high number, the country is significantly affected both economically and socially.
Many children missed school days due to asthma and some caregivers are also forced to leave work to take care of their sick children. As productivity of the country lowers, a lot of money is used in managing the disease (Rothe et al., 2018). However, treatment options have been improved to address the situation.
Both quick-relief and long control medicines are used in treating asthma. Long-term control medicines (also called controller medicines or maintenance medicines). Long-acting beta-adrenergic (LABA) is one of the quick relief medication used. The LABAs help in providing long-term control of symptoms (Kirenga et al., 2018).
Inhaled corticosteroids (ICS) are commonly used as anti-inflammatory drugs because they reduce inflammation caused by a vast diversity of inflammatory mediators (Yawn & Han, 2017). Rothe et al. (2018) highlight omalizumab (Xolair) as the most common Immuno-modulators used to prevent the binding of IgE to its receptor and in turn, inhibit IgE-mediated asthma from cascading before it begins.
STEP 1. Step one and two are recommended for all ages. In asthma treatment, inhaled corticosteroids (ICS) are commonly used as anti-inflammatory drugs because they reduce inflammation caused by a vast diversity of inflammatory mediators (Yawn & Han, 2017). STEP 2. Referrals can be considered for ages between 0-4 (White et al., 2018). This treatment is recommended for patients who show no improvement in step one.
The intensity of the medications are increased, and other treatment options are introduced to address the problem. According to Yawn & Han (2017), leukotriene receptor antagonists (LTRAs) are introduced as the alternative category of drugs because they help in blocking leukotrienes from binding to the proinflammatory cells in the airways. Most commonly used LTRAs are montelukast, which is effective in allergic asthma.
STEP 3. According to Yawn and Han (2017), this step applies for ages above 12 years. At this stage, either the ICS dose is increased, or a long-acting beta-adrenergic (LABA) is added. The LABAs help in providing long-term control of symptoms (Kirenga et al., 2018). Some of the most commonly used combinations of LABAs and ICS (ICS/LABA) are fluticasone + salmeterol (available as a dry powder inhaler) and formoterol + budesonide (available as an HFA inhaler) (Yawn & Han, 2017). STEP 4. Applies for ages above 12 years. Also, patients who experience recurring severe exacerbations requiring ED visits, oral prednisone, or hospitalizations should be considered for this step. The same applies for patient of ages between 5 and 11.
Click here to ORDER an A++ paper from our Verified MASTERS and DOCTORATE WRITERS: ASTHMA AND STEPWISE MANAGEMENT NURS 6521
STEP 5. Applies for ages above 12 years. For ages between 5-11 years, Rothe et al. (2018) recommends a High-dose inhaled steroid plus long-acting beta-agonist. Alternative can be a High-dose inhaled steroid plus leukotriene blocker. Rothe et al. (2018) highlight omalizumab (Xolair) as the most common Immuno-modulators used to prevent the binding of IgE to its receptor and in turn, inhibit IgE-mediated asthma from cascading before it begins.
STEP 6. Applies for ages above 12 years. For age 5-11 years, a High-dose inhaled steroid plus long-acting beta-agonist are preferred. A combination of High-dose inhaled steroid, either long-acting beta-agonist or leukotriene blocker, oral steroid is preferred for age 0-4.
In 2007, the National Asthma Education and Prevention Program (NAEPP) published its third report, which reinforced the guidelines for the Diagnosis and Management of Asthma. According to Rothe et al. (2018), the Expert Panel recommends that asthma therapy should be aimed at maintaining control of the disease with the least amount of medication which, in turn, minimizes the risks for adverse effects.
The stepwise approach increases or decreases the dose administered and also changes them and their frequency till the best medication and with its best amount and frequency of dosage is established. Efforts are focused on suppressing inflammation over the long term and preventing exacerbations (Yokoyama & Yokoyama, 2019).
REFERENCES
uKirenga, B. J., Schwartz, J. I., de Jong, C., van der Molen, T., & Okot-Nwang, M. (2015). Guidance on the diagnosis and management of asthma among adults in resource limited settings. African health sciences, 15(4), 1189-1199.
uRothe, T., Spagnolo, P., Bridevaux, P. O., Clarenbach, C., Eich-Wanger, C., Meyer, F., & Sauty, A. (2018). Diagnosis and management of asthma–the swiss guidelines. Respiration, 95(5), 364-380.
uYawn, B. P., & Han, M. K. (2017, November). Practical considerations for the diagnosis and management of asthma in older adults. In Mayo Clinic Proceedings (Vol. 92, No. 11, pp. 1697-1705). Elsevier.
uWhite, J., Paton, J. Y., Niven, R., & Pinnock, H. (2018). Guidelines for the diagnosis and management of asthma: a look at the key differences between BTS/SIGN and NICE. Thorax, 73(3), 293-297.
Asthma is a respiratory disorder that affects children and adults. Advanced practice nurses often provide treatment to patients with these disorders. Sometimes patients require immediate treatment, making it essential that you recognize and distinguish minor asthma symptoms from serious, life-threatening ones.
Since symptoms and attacks are often induced by a trigger, advanced practice nurses must also help patients identify their triggers and recommend appropriate management options. Like many other disorders, there are various approaches to treating and managing care for asthmatic patients depending on individual patient factors.
Understanding the dynamics of an illness and its severity is crucial to effective treatment and management. Current statistics depict asthma as a genuine global health concern since it affects approximately 235 million people worldwide (Beasley et al., 2021). To offer an appropriate intervention, healthcare practitioners should understand asthma’s manifestations and how patients experience and cope with it.
Asthma usually results in sporadic or persistent respiratory symptoms characterized by cough, shortness of breath, and other signs (Papi et al., 2020). When designing and implementing the care plan, healthcare professionals should prioritize anti-inflammatory treatment due to asthma’s capacity to limit airflow. The patient should be actively involved in developing the action plan to promote patient-centeredness and medication adherence.
| Criteria | Ratings | Pts | ||||
|---|---|---|---|---|---|---|
|
Describe the long-term control and quick relief treatment options for the asthma patient from your practice, as well as the impact these drugs might have on your patient. |
| |||||
|
Explain the stepwise approach to asthma treatment and management for your patient. |
| |||||
|
Explain how stepwise management assists health care providers and patients in gaining and maintaining control of the disease. Be specific. |
| |||||
|
Written Expression and Formatting – Paragraph Development and Organization: Paragraphs make clear points that support well developed ideas, flow logically, and demonstrate continuity of ideas. Sentences are carefully focused–neither long and rambling nor short and lacking substance. |
| |||||
|
Written Expression and Formatting – English writing standards: Correct grammar, mechanics, and proper punctuation |
| |||||
|
Total Points: 100
| ||||||
Asthma is a respiratory disorder that affects children and adults. Advanced practice nurses often provide treatment to patients with these disorders. Sometimes patients require immediate treatment, making it essential that you recognize and distinguish minor asthma symptoms from serious, life-threatening ones. Since symptoms and attacks are often induced by a trigger, advanced practice nurses must also help patients identify their triggers and recommend appropriate management options. Like many other disorders, there are various approaches to treating and managing care for asthmatic patients depending on individual patient factors.
One method that supports the clinical decision making of drug therapy plans for asthmatic patients is the stepwise approach, which you explore in this Assignment.
RESOURCES
Be sure to review the Learning Resources before completing this activity.
Click the weekly resources link to access the resources.
WEEKLY RESOURCES
To Prepare:
- Reflect on drugs used to treat asthmatic patients, including long-term control and quick relief treatment options for patients. Think about the impact these drugs might have on patients, including adults and children.
- Consider how you might apply the stepwise approach to address the health needs of a patient in your practice.
- Reflect on how stepwise management assists health care providers and patients in gaining and maintaining control of the disease.
BY DAY 7 OF WEEK 3
Create a 5- to 6-slide PowerPoint presentation that can be used in a staff development meeting on presenting different approaches for implementing the stepwise approach for asthma treatment. Be sure to address the following:
- Describe long-term control and quick relief treatment options for the asthma patient from your practice as well as the impact these drugs might have on your patient.
- Explain the stepwise approach to asthma treatment and management for your patient.
- Explain how stepwise management assists health care providers and patients in gaining and maintaining control of the disease. Be specific.
SUBMISSION INFORMATION
Before submitting your final assignment, you can check your draft for authenticity. To check your draft, access the Turnitin Drafts from the Start Here area.
- To submit your completed assignment, save your Assignment as WK3Assgn_LastName_Firstinitial
- Then, click on Start Assignment near the top of the page.
- Next, click on Upload File and select Submit Assignment for review.
Rubric
NURS_6521_Week3_Assignment_Rubric
| NURS_6521_Week3_Assignment_Rubric | ||
| Criteria | Ratings | Pts |
| This criterion is linked to a Learning OutcomeDescribe the long-term control and quick relief treatment options for the asthma patient from your practice, as well as the impact these drugs might have on your patient. | 30 to >26.0 pts Excellent The presentation clearly and accurately describes in detail the long-term control and quick relief treatment options for the asthma patient from their practice. … The presentation clearly and accurately describes in detail the impact these drugs might have on their patient. 26 to >23.0 pts Good The presentation accurately describes the long-term control and quick relief options for the asthma patient from their practice. … The presentation accurately describes the impact these drugs might have on their patient. 23 to >20.0 pts Fair The presentation inaccurately or vaguely describes the long-term control and quick relief options for the asthma patient from their practice. … The presentation inaccurately or vaguely describes the impact these drugs might have on their patient. 20 to >0 pts Poor The presentation inaccurately and vaguely describes the long-term and quick relief options for the asthma patient from their practice, or is missing. … The presentation inaccurately and vaguely describes the impact these drugs might have on their patient, or is missing. | 30 pts |
| This criterion is linked to a Learning OutcomeExplain the stepwise approach to asthma treatment and management for your patient. | 30 to >26.0 pts Excellent The presentation clearly and accurately explains in detail the stepwise approach to asthma treatment and management for their patient. 26 to >23.0 pts Good The presentation accurately explains the stepwise approach to asthma treatment and management for their patient. 23 to >20.0 pts Fair The presentation inaccurately or vaguely explains the stepwise approach to asthma treatment and management for their patient. 20 to >0 pts Poor The presentation inaccurately and vaguely explains the stepwise approach to asthma treatment and management for their patient. | 30 pts |
| This criterion is linked to a Learning OutcomeExplain how stepwise management assists health care providers and patients in gaining and maintaining control of the disease. Be specific. | 30 to >26.0 pts Excellent The presentation clearly and accurately explains in detail how stepwise management assists health care providers and patients in gaining and maintaining control of the disease. … The presentation provides accurate and detailed examples to support the explanation provided. 26 to >23.0 pts Good The presentation accurately explains how stepwise management assists health care providers and patients in gaining and maintaining control of the disease. … The presentation provides accurate examples to support the explanation provided. 23 to >20.0 pts Fair The presentation inaccurately or vaguely explains how stepwise management assists health care providers and patients in gaining and maintaining control of the disease. … The presentation provides inaccurate or vague examples to support the explanation provided. 20 to >0 pts Poor The presentation inaccurately and vaguely explains how stepwise management assists health care providers and patients in gaining and maintaining control of the disease, or is missing. … The presentation provides inaccurate and vague examples to support the explanation provided, or is missing. | 30 pts |
| This criterion is linked to a Learning OutcomeWritten Expression and Formatting – Paragraph Development and Organization: Paragraphs make clear points that support well developed ideas, flow logically, and demonstrate continuity of ideas. Sentences are carefully focused–neither long and rambling nor short and lacking substance. | 5 to >4.0 pts Excellent Paragraphs and sentences follow writing standards for flow, continuity, and clarity. 4 to >3.5 pts Good Paragraphs and sentences follow writing standards for flow, continuity, and clarity 80% of the time. 3.5 to >3.0 pts Fair Paragraphs and sentences follow writing standards for flow, continuity, and clarity 60%–79% of the time. 3 to >0 pts Poor Paragraphs and sentences follow writing standards for flow, continuity, and clarity less than 60% of the time. | 5 pts |
| This criterion is linked to a Learning OutcomeWritten Expression and Formatting – English writing standards: Correct grammar, mechanics, and proper punctuation | 5 to >4.0 pts Excellent Uses correct grammar, spelling, and punctuation with no errors 4 to >3.5 pts Good Contains a few (1–2) grammar, spelling, and punctuation errors 3.5 to >3.0 pts Fair Contains several (3–4) grammar, spelling, and punctuation errors 3 to >0 pts Poor Contains many (≥ 5) grammar, spelling, and punctuation errors that interfere with the reader’s understanding | 5 pts |
| Total Points: 100 | ||
Don’t wait until the last minute
Fill in your requirements and let our experts deliver your work asap.